Project highlights: Sichuan Yuanda Shuyang Pharmaceutical Co., Ltd., as a leading enterprise engaged in the domestic blood products industry, has the products of 8 varieties and 23 specifications, including human albumin, intravenous injection of human immunoglobulin, intravenous injection of hepatitis B human immunoglobulin and hepatitis B human immunoglobulin. Independently innovated double-virus inactivation process without protective agent won patents from the United States, Australia and China; Independently researched and developed intravenous hepatitis B human immunoglobulin is the first listed product in Asia and the fourth in the world, and has won the awards such as National Key New Product, First Prize for Scientific and Technological Progress Award in Sichuan Province and the Outstanding Scientific and Technological Contribution Award in Chengdu.

In this project, our company serves as the contractor of whole purification electromechanical engineering, and through construction of this project construction, it can continuously enhance our reputation and prestige in the field of blood products. It plays the leading and benchmarking role in the development of the industry.

Aerial view	Clean area